Toronto Dominion Bank’s Checkpoint Therapeutics CKPT Stock Holding History

Toronto Dominion Bank’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,424,522	Closed	-$13.8M	–	1846
2025 Q1	$13.8M	Buy	+3,424,522	New	+$11.4M	0.03%	408

Toronto Dominion Bank's CKPT Position: Q2 2025 in Review

Toronto Dominion Bank sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 3,424,522 shares — an estimated $13.8M sold.

Toronto Dominion Bank first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $13.8M in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Toronto Dominion Bank reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Toronto Dominion Bank sold 3,424,522 Checkpoint Therapeutics shares in Q2 2025, an estimated $13.8M.
Toronto Dominion Bank first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
Toronto Dominion Bank's Checkpoint Therapeutics position peaked at $13.8M in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Toronto Dominion Bank's 13F filing for Q2 2025, filed 14 Aug 2025.